SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-009624
Filing Date
2024-06-28
Accepted
2024-06-28 16:33:49
Documents
14
Period of Report
2024-06-27
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K fbio-20240627x8k.htm   iXBRL 8-K 36070
  Complete submission text file 0001558370-24-009624.txt   192959

Data Files

Seq Description Document Type Size
2 EX-101.SCH fbio-20240627.xsd EX-101.SCH 4461
3 EX-101.DEF fbio-20240627_def.xml EX-101.DEF 14890
4 EX-101.LAB fbio-20240627_lab.xml EX-101.LAB 17165
5 EX-101.PRE fbio-20240627_pre.xml EX-101.PRE 14855
17 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20240627x8k_htm.xml XML 7218
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 241086251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)